Relapse During Rituximab Induction for PR3-ANCA-Associated Vasculitis with Pauci-Immune Crescentic Glomerulonephritis and Diffuse Alveolar Hemorrhage (DAH) (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0797; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Patient was discharged on Rituximab induction therapy with prednisone taper...After third dose, patient presented with DAH and worsened renal function which responded to steroids, plasmapheresis and cyclophosphamide before transferring to a Vasculitis Center due to concern of Rituximab failure...The learning point in this case is that Rituximab did not fail as induction therapy, rather a relapse due to infection. However, resistant disease is important to keep in mind during induction relapses."
ANCA Vasculitis • Fibrosis • Glomerulonephritis • Hematological Disorders • Immunology • Infectious Disease • Lupus Nephritis • Musculoskeletal Diseases • Nephrology • Pneumonia • Rare Diseases • Renal Disease • Respiratory Diseases • Vasculitis
|
|
Trent E. Rich; Austin L. Carey; Jaleel Jerry Sweis; Xueguang (Gary) Chen
|